Clearstate’s study in APAC provides analytical insights on top ophthalmic pharmaceutical suppliers.

The APAC ophthalmic pharmaceutical markets reached USD 2.6 billion in 2008-09, With Japan taking up nearly 70% of the total market. Japan’s ophthalmic market was the first to be developed, when such international suppliers as Pfizer and Alcon entered the market some 30 years ago. Besides Japan, the International suppliers entered the ophthalmic markets in APAC only in the 1990s, and countries like South Korea, India and SEA are currently reporting yearly growth rates in excess of 10%. The other substantial ophthalmic pharmaceutical markets in APAC are China, South Korea and Australia Together, these 4 largest markets account for over 85% of the total APAC market by value.